These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7660310)

  • 41. Liposomes as a potential ocular delivery system of distamycin A.
    Chetoni P; Monti D; Tampucci S; Matteoli B; Ceccherini-Nelli L; Subissi A; Burgalassi S
    Int J Pharm; 2015 Aug; 492(1-2):120-6. PubMed ID: 26183332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A preliminary study of corneal penetration of 125I-labelled idoxuridine liposome.
    Dharma SK; Fishman PH; Peyman GA
    Acta Ophthalmol (Copenh); 1986 Jun; 64(3):298-301. PubMed ID: 3751519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Possible eye-irritant test using polysaccharide-coated liposomes as a corneal epithelium model.
    Sunamoto J; Iwamoto K; Imokawa G; Tsuchiya S
    Chem Pharm Bull (Tokyo); 1987 Jul; 35(7):2958-65. PubMed ID: 3677247
    [No Abstract]   [Full Text] [Related]  

  • 44. Liposomes coated with chemically modified dextran interact with human endothelial cells.
    Cansell M; Parisel C; Jozefonvicz J; Letourneur D
    J Biomed Mater Res; 1999 Feb; 44(2):140-8. PubMed ID: 10397914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liposome transduction into cells enhanced by haptotactic peptides (Haptides) homologous to fibrinogen C-termini.
    Gorodetsky R; Levdansky L; Vexler A; Shimeliovich I; Kassis I; Ben-Moshe M; Magdassi S; Marx G
    J Control Release; 2004 Mar; 95(3):477-88. PubMed ID: 15023459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of liposomes with human skin in vitro--the influence of lipid composition and structure.
    Kirjavainen M; Urtti A; Jääskeläinen I; Suhonen TM; Paronen P; Valjakka-Koskela R; Kiesvaara J; Mönkkönen J
    Biochim Biophys Acta; 1996 Dec; 1304(3):179-89. PubMed ID: 8982264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interactions of PC/Chol and PS/Chol liposomes with human cells in vitro.
    Papadimitriou E; Antimisiaris SG
    J Drug Target; 2000; 8(5):335-51. PubMed ID: 11328660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Location of penetration and metabolic barriers to levobunolol in the corneal epithelium of the pigmented rabbit.
    Ashton P; Wang W; Lee VH
    J Pharmacol Exp Ther; 1991 Nov; 259(2):719-24. PubMed ID: 1941620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Artificial tear composition and promotion of recovery of the damaged corneal epithelium.
    Lopez Bernal D; Ubels JL
    Cornea; 1993 Mar; 12(2):115-20. PubMed ID: 8500317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytotoxicity of viscoelastics on cultured corneal epithelial cells measured by plasminogen activator release.
    Lindquist TD; Edenfield M
    J Refract Corneal Surg; 1994; 10(2):95-102. PubMed ID: 7517294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of liposomes to introduce substances into pancreatic islet cells.
    Welsh N; Hallberg A; Sandler S; Hellerström C
    Diabetes; 1988 Aug; 37(8):1123-8. PubMed ID: 3292331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular evidence and functional expression of a novel drug efflux pump (ABCC2) in human corneal epithelium and rabbit cornea and its role in ocular drug efflux.
    Karla PK; Pal D; Quinn T; Mitra AK
    Int J Pharm; 2007 May; 336(1):12-21. PubMed ID: 17156953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Amphotericin B--bioavailability in the cornea. Studies with local administration of liposome incorporated amphotericin B].
    Pleyer U; Grammer J; Pleyer JH; Kosmidis P; Friess D; Schmidt KH; Thiel HJ
    Ophthalmologe; 1995 Aug; 92(4):469-75. PubMed ID: 7549331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pulmonary effects of chronic exposure to liposome aerosols in mice.
    Myers MA; Thomas DA; Straub L; Soucy DW; Niven RW; Kaltenbach M; Hood CI; Schreier H; Gonzalez-Rothi RJ
    Exp Lung Res; 1993; 19(1):1-19. PubMed ID: 8440200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phagocytosis of liposomes by human platelets.
    Male R; Vannier WE; Baldeschwieler JD
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9191-5. PubMed ID: 1409624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modeling cytoplasmic release of encapsulated oligonucleotides from cationic liposomes.
    Tamaddon AM; Shirazi FH; Moghimi HR
    Int J Pharm; 2007 May; 336(1):174-82. PubMed ID: 17196349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative analysis of liposome-cell interactions in vitro: rate constants of binding and endocytosis with suspension and adherent J774 cells and human monocytes.
    Lee KD; Nir S; Papahadjopoulos D
    Biochemistry; 1993 Jan; 32(3):889-99. PubMed ID: 8422393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liposomes and pulmonary alveolar macrophages: functional and morphologic interactions.
    Gonzalez-Rothi RJ; Straub L; Cacace JL; Schreier H
    Exp Lung Res; 1991; 17(4):687-705. PubMed ID: 1657589
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ocular delivery of cyanidin-3-glycoside in liposomes and its prevention of selenite-induced oxidative stress.
    Zhang J; Liang X; Li X; Guan Z; Liao Z; Luo Y; Luo Y
    Drug Dev Ind Pharm; 2016; 42(4):546-53. PubMed ID: 26393779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Shedding of tumor cell surface membranes.
    Liepins A; Hillman AJ
    Cell Biol Int Rep; 1981 Jan; 5(1):15-26. PubMed ID: 6784933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.